Table 2 Patient demographics, outcomes and standard coagulation studies
From: Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery
All (n =313) | No thromboembolic complication (n =303) | Thromboembolic complication (n =10) | P-value | |
|---|---|---|---|---|
Age, years | 58.7 (+/−15.2) | 58.5 (+/-15.2) | 63.6 (+/-16.1) | 0.30 |
Body mass index, kg/m2 | 27.7 (+/-6.3) | 27.8 (+/-6.3) | 26.4 (+/-4.8) | 0.49 |
Obesity | 102 (32.6%) | 99 (32.7%) | 3 (30%) | 0.57 |
Female | 165 (53%) | 161 (53%) | 4 (40%) | 0.88 |
Surgery class | ||||
Major abdominal | 85 (27%) | 81 (27%) | 4 (40%) | 0.47 |
Gynecological | 4 (1%) | 4 (1%) | 0 (0%) | 1.0 |
Central nervous system neurosurgery | 48 (15%) | 48 (16%) | 0 (0% | 0.37 |
Spine | 62 (20%) | 60 (20%) | 2 (20%) | 1.0 |
Vascular | 11 (4%) | 11 (4%) | 0 (0%) | 1.0 |
Urology | 26 (8%) | 23 (8%) | 3 (30%) | 0.04 |
Orthopedics | 29 (9%) | 29 (10%) | 0 (0%) | 0.60 |
Liver surgery | 20 (6%) | 19 (6%) | 1 (10%) | 0.49 |
Renal transplant | 24 (8%) | 24 (8%) | 0 (0%) | 1.0 |
Other | 4 (1%) | 4 (1%) | 0 (0%) | 1.0 |
Cancer | 147 (47.0%) | 141 (46.5%) | 6 (60%) | 0.62 |
End-stage renal disease | 17 (5.4%) | 17 (5.6%) | 0 (0%) | 1.0 |
Outcomes | ||||
ICU length of stay, days | 1.1 (+/-3.8) | 0.9 (+/-3.4) | 5.7 (+/-9.7) | 0.15 |
Hospital length of stay, days | 6.8 (+/-10.1) | 6.2 (+/-7.8) | 25.5 (+/-32.4) | 0.09 |
Myocardial infarction | 3 (1%) | 3 (1%) | 0 (0%) | 1.0 |
Acute kidney injury (RIFLE-risk) | 12 (3.8%) | 12 (3.9%) | 0 (0%) | 1.0 |
Standard postoperative coagulation studies | ||||
Prothrombin time, s | 32.3 (+/-11.6) | 32.3 (+/-11.8) | 33.1 (+/-6.2) | 0.89 |
International normalized ratio | 1.20 (+/-0.24) | 1.20 (+/-0.25) | 1.28 (+/-0.11) | 0.39 |
Platelet count | 201 (+/-67) | 201 (+/-68) | 212 (+/-69) | 0.63 |